Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
hydroxyureamethylacylfulvene (STAR-001)
i
Other names:
STAR-001, LP-184, irofulven-2, irofulven-second-generation
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(16)
News
Trials
Company:
Lantern Pharma
Drug class:
Alkylating agent
Related drugs:
‹
carboplatin (208)
cyclophosphamide (66)
trabectedin (24)
lomustine (15)
carmustine (14)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
temozolomide gel (7)
D19466 (4)
procarbazine hydrochloride (4)
OBI-3424 (4)
mitomycin (3)
thiotepa (3)
bendamustine RTD (2)
busulfan (2)
VAL-083 (2)
LP-284 (2)
fotemustine (2)
ACHM-025 (1)
BYON4413 (1)
IMGS-101 (1)
FGX15-147-based ADC (1)
treosulfan (1)
EX-204 (0)
bendamustine rapid infusion (0)
captisol-enabled melphalan (0)
cyclophosphamide intravenous (0)
ranimustine (0)
carmustine implant (0)
D 19575 (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
pegylated liposomal mitomycin-c prodrug (0)
QBS72S (0)
CB1954 (0)
mechlorethamine gel (0)
carboplatin (208)
cyclophosphamide (66)
trabectedin (24)
lomustine (15)
carmustine (14)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
temozolomide gel (7)
D19466 (4)
procarbazine hydrochloride (4)
OBI-3424 (4)
mitomycin (3)
thiotepa (3)
bendamustine RTD (2)
busulfan (2)
VAL-083 (2)
LP-284 (2)
fotemustine (2)
ACHM-025 (1)
BYON4413 (1)
IMGS-101 (1)
FGX15-147-based ADC (1)
treosulfan (1)
EX-204 (0)
bendamustine rapid infusion (0)
captisol-enabled melphalan (0)
cyclophosphamide intravenous (0)
ranimustine (0)
carmustine implant (0)
D 19575 (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
pegylated liposomal mitomycin-c prodrug (0)
QBS72S (0)
CB1954 (0)
mechlorethamine gel (0)
›
Associations
(16)
News
Trials
VERI cancer hierarchy
Reset Filters
CASP6 overexpression
Non Small Cell Lung Cancer
CASP6 overexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
HPGD underexpression
Non Small Cell Lung Cancer
HPGD underexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
PTPRF underexpression
Non Small Cell Lung Cancer
PTPRF underexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
KRT14 underexpression
Non Small Cell Lung Cancer
KRT14 underexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
NAMPT overexpression
Non Small Cell Lung Cancer
NAMPT overexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
SMARCD3 overexpression
Non Small Cell Lung Cancer
SMARCD3 overexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
GLRX overexpression
Non Small Cell Lung Cancer
GLRX overexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
KDM4A underexpression
Non Small Cell Lung Cancer
KDM4A underexpression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
PTGR1 expression
Non Small Cell Lung Cancer
PTGR1 expression
Non Small Cell Lung Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
PTGR1 elevation + HRD
Prostate Cancer
PTGR1 elevation + HRD
Prostate Cancer
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
PTGR1 elevation + HRD
Pancreatic Adenocarcinoma
PTGR1 elevation + HRD
Pancreatic Adenocarcinoma
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
PTGR1 elevation + HRD
Lung Adenocarcinoma
PTGR1 elevation + HRD
Lung Adenocarcinoma
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
STAR-001
Sensitive: D – Preclinical
STAR-001
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.